Literature DB >> 26635353

Determination of sites of U50,488H-promoted phosphorylation of the mouse κ opioid receptor (KOPR): disconnect between KOPR phosphorylation and internalization.

Chongguang Chen1, Yi-Ting Chiu1, Wenman Wu1, Peng Huang1, Anika Mann2, Stefan Schulz2, Lee-Yuan Liu-Chen3.   

Abstract

Phosphorylation sites of KOPR (κ opioid receptor) following treatment with the selective agonist U50,488H {(-)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)cyclo-hexyl]benzeneacetamide} were identified after affinity purification, SDS/PAGE, in-gel digestion with Glu-C and HPLC-MS/MS. Single- and double-phosphorylated peptides were identified containing phosphorylated Ser(356), Thr(357), Thr(363) and Ser(369) in the C-terminal domain. Antibodies were generated against three phosphopeptides containing pSer(356)/pThr(357), pThr(363) and pSer(369) respectively, and affinity-purified antibodies were found to be highly specific for phospho-KOPR. U50,488H markedly enhanced staining of the KOPR by pThr(363)-, pSer(369)- and pSer(356)/pThr(357)-specific antibodies in immunoblotting, which was blocked by the selective KOPR antagonist norbinaltorphimine. Ser(369) phosphorylation affected Thr(363) phosphorylation and vice versa, and Thr(363) or Ser(369) phosphorylation was important for Ser(356)/Thr(357) phosphorylation, revealing a phosphorylation hierarchy. U50,488H, but not etorphine, promoted robust KOPR internalization, although both were full agonists. U50,488H induced higher degrees of phosphorylation than etorphine at Ser(356)/Thr(357), Thr(363) and Ser(369) as determined by immunoblotting. Using SILAC (stable isotope labelling by amino acids in cell culture) and HPLC-MS/MS, we found that, compared with control (C), U50,488H (U) and etorphine (E) KOPR promoted single phosphorylation primarily at Thr(363) and Ser(369) with U/E ratios of 2.5 and 2 respectively. Both induced double phosphorylation at Thr(363)+Ser(369) and Thr(357)+Ser(369) with U/E ratios of 3.3 and 3.4 respectively. Only U50,488H induced triple phosphorylation at Ser(356)+Thr(357)+Ser(369). An unphosphorylated KOPR-(354-372) fragment containing all of the phosphorylation sites was detected with a C/E/U ratio of 1/0.7/0.4, indicating that ∼60% and ∼30% of the mouse KOPR are phosphorylated following U50,488H and etorphine respectively. Thus KOPR internalization requires receptor phosphorylation above a certain threshold, and higher-order KOPR phosphorylation may be disproportionally important.
© 2016 Authors; published by Portland Press Limited.

Entities:  

Keywords:  SILAC; endocytosis threshold; phospho-κ opioid receptor-specific antibody; phosphorylation sites; κ opioid receptor

Mesh:

Substances:

Year:  2015        PMID: 26635353      PMCID: PMC5444940          DOI: 10.1042/BJ20141471

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  How reliable are G-protein-coupled receptor antibodies?

Authors:  Martin C Michel; Thomas Wieland; Gozoh Tsujimoto
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-01-27       Impact factor: 3.000

2.  Quantitative encoding of the effect of a partial agonist on individual opioid receptors by multisite phosphorylation and threshold detection.

Authors:  Elaine K Lau; Michelle Trester-Zedlitz; Jonathan C Trinidad; Sarah J Kotowski; Andrew N Krutchinsky; Alma L Burlingame; Mark von Zastrow
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

3.  Mass spectrometric analysis of agonist effects on posttranslational modifications of the beta-2 adrenoceptor in mammalian cells.

Authors:  Michelle Trester-Zedlitz; Al Burlingame; Brian Kobilka; Mark von Zastrow
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

4.  U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.

Authors:  P F Vonvoigtlander; R A Lahti; J H Ludens
Journal:  J Pharmacol Exp Ther       Date:  1983-01       Impact factor: 4.030

5.  Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.

Authors:  Michael R Bruchas; Benjamin B Land; Megumi Aita; Mei Xu; Sabiha K Barot; Shuang Li; Charles Chavkin
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

6.  Phosphorylation of a carboxyl-terminal serine within the kappa-opioid receptor produces desensitization and internalization.

Authors:  Jay P McLaughlin; Mei Xu; Ken Mackie; Charles Chavkin
Journal:  J Biol Chem       Date:  2003-06-18       Impact factor: 5.157

Review 7.  Agonist-induced regulation and trafficking of kappa opioid receptors.

Authors:  Lee-Yuan Liu-Chen
Journal:  Life Sci       Date:  2004-06-18       Impact factor: 5.037

8.  Development of functionally selective, small molecule agonists at kappa opioid receptors.

Authors:  Lei Zhou; Kimberly M Lovell; Kevin J Frankowski; Stephen R Slauson; Angela M Phillips; John M Streicher; Edward Stahl; Cullen L Schmid; Peter Hodder; Franck Madoux; Michael D Cameron; Thomas E Prisinzano; Jeffrey Aubé; Laura M Bohn
Journal:  J Biol Chem       Date:  2013-11-01       Impact factor: 5.157

9.  Distinct phosphorylation sites on the β(2)-adrenergic receptor establish a barcode that encodes differential functions of β-arrestin.

Authors:  Kelly N Nobles; Kunhong Xiao; Seungkirl Ahn; Arun K Shukla; Christopher M Lam; Sudarshan Rajagopal; Ryan T Strachan; Teng-Yi Huang; Erin A Bressler; Makoto R Hara; Sudha K Shenoy; Steven P Gygi; Robert J Lefkowitz
Journal:  Sci Signal       Date:  2011-08-09       Impact factor: 8.192

10.  Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.

Authors:  Adrian J Butcher; Rudi Prihandoko; Kok Choi Kong; Phillip McWilliams; Jennifer M Edwards; Andrew Bottrill; Sharad Mistry; Andrew B Tobin
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

View more
  15 in total

1.  Modulation of serotonin transporter function by kappa-opioid receptor ligands.

Authors:  Santhanalakshmi Sundaramurthy; Balasubramaniam Annamalai; Devadoss J Samuvel; Toni S Shippenberg; Lankupalle D Jayanthi; Sammanda Ramamoorthy
Journal:  Neuropharmacology       Date:  2016-10-12       Impact factor: 5.250

Review 2.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

3.  Agonist-promoted kappa opioid receptor (KOR) phosphorylation has behavioral endpoint-dependent and sex-specific effects.

Authors:  Peng Huang; Chongguang Chen; Danni Cao; Melody Huang; Lee-Yuan Liu-Chen
Journal:  Neuropharmacology       Date:  2021-11-02       Impact factor: 5.273

4.  Agonist-Dependent and -Independent κ Opioid Receptor Phosphorylation: Distinct Phosphorylation Patterns and Different Cellular Outcomes.

Authors:  Yi-Ting Chiu; Chongguang Chen; Daohai Yu; Stefan Schulz; Lee-Yuan Liu-Chen
Journal:  Mol Pharmacol       Date:  2017-09-11       Impact factor: 4.436

5.  Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion.

Authors:  Jeffrey J Liu; Yi-Ting Chiu; Kelly M DiMattio; Chongguang Chen; Peng Huang; Taylor A Gentile; John W Muschamp; Alan Cowan; Matthias Mann; Lee-Yuan Liu-Chen
Journal:  Neuropsychopharmacology       Date:  2018-07-20       Impact factor: 7.853

6.  Considerations on Using Antibodies for Studying the Dynorphins/Kappa Opioid Receptor System.

Authors:  Chongguang Chen; Melanie Widmann; Christoph Schwarzer; Lee-Yuan Liu-Chen
Journal:  Handb Exp Pharmacol       Date:  2022

7.  Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.

Authors:  Catherine Cahill; Hugo A Tejeda; Mariana Spetea; Chongguang Chen; Lee-Yuan Liu-Chen
Journal:  Handb Exp Pharmacol       Date:  2022

8.  Mechanism Governing Human Kappa-Opioid Receptor Expression under Desferrioxamine-Induced Hypoxic Mimic Condition in Neuronal NMB Cells.

Authors:  Jennifer Babcock; Alberto Herrera; George Coricor; Christopher Karch; Alexander H Liu; Aida Rivera-Gines; Jane L Ko
Journal:  Int J Mol Sci       Date:  2017-01-20       Impact factor: 5.923

Review 9.  Novel Structural Approaches to Study GPCR Regulation.

Authors:  Marco A Alfonzo-Méndez; Rocío Alcántara-Hernández; J Adolfo García-Sáinz
Journal:  Int J Mol Sci       Date:  2016-12-23       Impact factor: 5.923

10.  Pharmacological and phosphoproteomic approaches to roles of protein kinase C in kappa opioid receptor-mediated effects in mice.

Authors:  Jeffrey J Liu; Yi-Ting Chiu; Chongguang Chen; Peng Huang; Matthias Mann; Lee-Yuan Liu-Chen
Journal:  Neuropharmacology       Date:  2020-09-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.